Effectiveness of a combination therapy in the Parkinson syndrome by amantadine hydrochloride and anticholinergic agents
Gospavić, J.; Vidaković, Z.
Srpski Arhiv Za Celokupno Lekarstvo 102(6): 447-457
1974
ISSN/ISBN: 0370-8179 PMID: 4450143 Document Number: 81119
Document emailed within 1 workday
Related Documents
Silver, D.E.; Sahs, A.L. 1971: Double blind study using amantadine hydrochloride in the therapy of Parkinson's disease Transactions of the American Neurological Association 96: 307-308Nakamura, H.; Uyama, H.; Enomoto, H.; Kishima, Y.; Yamamoto, M.; Yoshida, K.; Okuda, Y.; Hirotani, T.; Kuroda, T.; Ito, H.; Matsuda, M.; Terabayashi, M.; Noguchi, S. 2003: The combination therapy of interferon and amantadine hydrochloride for patients with chronic hepatitis C Hepato-Gastroenterology 50(49): 222-226
Boushey, H.A. 1987: Combination therapy with anticholinergic agents for airflow obstruction Postgraduate Medical Journal 63(Suppl 1): 69-74
Griffiths, A.V.; Parker, W.N.; Palmer, R.M. 1971: Experiences with amantadine hydrochloride in Parkinson's disease Practitioner 207(241): 679-680
Nishiyama, K.; Mizuno, T.; Sakuta, M.; Kurisaki, H. 1993: Chronic dementia in Parkinson's disease treated by anticholinergic agents. Neuropsychological and neuroradiological examination Advances in Neurology 60: 479-483
Danielczyk, W. 1995: Twenty-five years of amantadine therapy in Parkinson's disease Journal of Neural Transmission. Supplementum 46: 399-405
Fischer, P.A.; Schneider, E.; Jacobi, P.; Maxion, H. 1973: Combination therapy of Parkinson's syndrome using L-dopa and a decarboxylase inhibitor Die Medizinische Welt 24(45): 1742-1746
Campanella, G.; Zallone, E.; Buscaino, G.A. 1972: Amantadine in the treatment of Parkinson's syndrome: studied in 31 patients for 3 months Acta Neurologica 27(5): 491-500
Chernov, A.P. 1972: Experience with the complex treatment of peptic ulcer by a combination of anticholinergic and anabolic agents Sovetskaia Meditsina 35(8): 104-108
Kadykov, A.S. 1976: The effectiveness of amantadine (midantan) in the treatment of the parkinsonian syndrome Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 76(2): 174-178
Bush, M.; Raath, J.P.; Phillips, L.G.; Lance, W. 2004: Immobilisation of impala (Aepyceros melampus) with a ketamine hydrochloride/medetomidine hydrochloride combination, and reversal with atipamezole hydrochloride Journal of the South African Veterinary Association 75(1): 14-18
Hatchuel, W.L. 1971: The effect of symmetrel (amantadine hydrochloride) on a case of athetosis South African Medical Journal 45(18): 499-500
Ambrosini, P.J.; Fried, J. 1984: Preliminary report: amantadine hydrochloride in childhood enuresis Journal of Clinical Psychopharmacology 4(4): 223-225
Ulmer, W.T.; Dorsch, J.; Iravani, J.; Schüler, K.G.; Stempel, G.; Vastag, E. 1973: Anticholinergic agents as bronchodilator agents. Significance of acetylcholine as a bronchoconstrictor transmitter agent in airway obstruction Arzneimittel-Forschung 23(3): 468-476
Campbell, A.M.; Williams, M.J. 1972: Trial of amantadine in Parkinson's disease British Journal of Clinical Practice 26(1): 19-22
Merrick, E.M.; Schmitt, P.P. 1973: A controlled study of the clinical effects of amantadine hydrochloride (Symmetrel) Current Therapeutic Research 15(8): 552-558
Ing, T.S.; Mahurkar, S.D.; Dunea, G.; Hayashi, J.A.; Klawans, H.L.; Markey, W.S. 1976: Removal of amantadine hydrochloride by dialysis in patients with renal insufficiency Canadian Medical Association Journal 115(6): 515
Veje, V.O. 1981: Drug information: antiparkinson agents. I. Anticholinergic agents Sygeplejersken 81(34): 11
Pendefunda, G.; Pollingher, B.; Stefanache, F.; Gavril, A.; Oprisan, C.; Merling, M.; Nemteanu, E.; Ciunru, M.; Koropitzer, I. 1975: The treatment with L-dopa and amantadine in Parkinson's disease Therapia Hungarica 23(1): 12-16
Ascher, P.W. 1976: Anticholinergic treatment of Parkinson's disease Wiener Klinische Wochenschrift 88(19): 641-646